☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-II trial
Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan
April 12, 2021
Allergen Announces Acquisition of Bonti for its Two Aesthetic and Therapeutic Products
September 17, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
